Targeting ferroptosis as a new paradigm for overcoming sorafenib resistance in hepatocellular carcinoma
- DOI
- 10.1016/j.bbcan.2026.189715
- Published
- 2026-11
- Container
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.bbcan.2026.189715,
title = {Targeting ferroptosis as a new paradigm for overcoming sorafenib resistance in hepatocellular carcinoma},
author = {Wenxuan Zhang and Wenhan Geng and Yumei Fan and Pengxiu Cao and Ke Tan},
year = {2026},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
doi = {10.1016/j.bbcan.2026.189715},
url = {https://doi.org/10.1016/j.bbcan.2026.189715}
}RIS
TY - JOUR TI - Targeting ferroptosis as a new paradigm for overcoming sorafenib resistance in hepatocellular carcinoma AU - Wenxuan Zhang AU - Wenhan Geng AU - Yumei Fan AU - Pengxiu Cao AU - Ke Tan PY - 2026 JO - Biochimica et Biophysica Acta (BBA) - Reviews on Cancer DO - 10.1016/j.bbcan.2026.189715 UR - https://doi.org/10.1016/j.bbcan.2026.189715 ER -
APA
Zhang, W., Geng, W., Fan, Y., Cao, P., & Tan, K. (2026). Targeting ferroptosis as a new paradigm for overcoming sorafenib resistance in hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2026.189715
Source records
- crossref · retrieved 2026-09-25T02:17:34.356Z